[Federal Register Volume 62, Number 59 (Thursday, March 27, 1997)]
[Notices]
[Pages 14682-14683]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-7726]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration
[Docket No. 96N-0487]


Agency Information Collection Activities; Announcement of OMB 
Approval

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

[[Page 14683]]

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Current Good Manufacturing 
Practices for Blood and Blood Components: Notification of Consignees 
Receiving Blood and Blood Components at Increased Risk for Transmitting 
HIV'' has been approved by the Office of Management and Budget (OMB) 
under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: Margaret R. Wolff, Office of 
Information Resources Management (HFA-250), Food and Drug 
Administration, 5600 Fishers Lane, rm. 16B-19, Rockville, MD 20857, 
301-827-1223.

SUPPLEMENTARY INFORMATION: In the Federal Register of December 27, 1996 
(61 FR 68268), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 
section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). 
OMB has now approved the information collection and has assigned OMB 
control number 0910-0336. The approval expires on February 28, 2000. An 
agency may not conduct or sponsor, and a person is not required to 
respond to, a collection of information unless it displays a currently 
valid OMB control number.

    Dated: March 19, 1997.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 97-7726 Filed 3-26-97; 8:45 am]
BILLING CODE 4160-01-F